Ligand Pharmaceuticals, Inc. (LGND)
243.50
+5.75
(+2.42%)
USD |
NASDAQ |
Jun 09, 16:00
243.50
0.00 (0.00%)
After-Hours: 20:00
Ligand Pharmaceuticals SG&A Expense (Quarterly) : 20.84M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Organon & Co. | 424.00M |
| Johnson & Johnson | 6.034B |
| Merck & Co., Inc. | 2.70B |
| ANI Pharmaceuticals, Inc. | 73.66M |
| Corcept Therapeutics, Inc. | 145.36M |